Insights

Clinical Trials

What the phase 2 retatrutide trial actually measured

Retatrutide's phase 2 data (NEJM, 2023) is the most-cited paper behind our product page. Here's what it actually measured, and where it stops short of answering the question researchers ask us most.

Asywa · 31 Jul 2026 · 1 min read